Focus Partners Wealth
GILD icon

Focus Partners Wealth’s Gilead Sciences GILD Stock Holding History

Focus Partners Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.7M Buy
550,578
+29,925
+6% +$4.19M 0.09% 223
2025
Q4 		$63.8M Buy
520,653
+131,310
+34% +$16M 0.07% 245
2025
Q3 		$43.2M Buy
389,343
+240,095
+161% +$27.3M 0.07% 234
2025
Q2 		$16.5M Buy
149,248
+6,582
+5% +$700K 0.04% 400
2025
Q1 		$16M Buy
142,666
+6,522
+5% +$673K 0.04% 377
2024
Q4 		$12.6M Buy
136,144
+33,456
+33% +$3.01M 0.03% 413
2024
Q3 		$8.61M Sell
102,688
-44,452
-30% -$3.39M 0.03% 440
2024
Q2 		$10.1M Buy
147,140
+84,455
+135% +$5.64M 0.03% 388
2024
Q1 		$4.59M Buy
62,685
+9,983
+19% +$768K 0.04% 334
2023
Q4 		$4.27M Buy
+52,702
New +$4.1M 0.06% 254

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Focus Partners Wealth's GILD Position: Q1 2026 in Review

Focus Partners Wealth increased its Gilead Sciences (GILD) stake by 5.7% in Q1 2026, buying an estimated $4.19M and bringing the position to 550,578 shares worth $76.7M. The position accounts for 0.09% of the portfolio, ranked #223.

Focus Partners Wealth first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Focus Partners Wealth held 550,578 shares of Gilead Sciences worth $76.7M as of Q1 2026.
  • Focus Partners Wealth bought 29,925 Gilead Sciences shares in Q1 2026, an estimated $4.19M.
  • Gilead Sciences made up 0.09% of Focus Partners Wealth's portfolio in Q1 2026, its #223 holding.
  • Focus Partners Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.